[go: up one dir, main page]

BR0309890A - Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação - Google Patents

Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação

Info

Publication number
BR0309890A
BR0309890A BR0309890-7A BR0309890A BR0309890A BR 0309890 A BR0309890 A BR 0309890A BR 0309890 A BR0309890 A BR 0309890A BR 0309890 A BR0309890 A BR 0309890A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
treatment
lesions
well
composition containing
Prior art date
Application number
BR0309890-7A
Other languages
English (en)
Inventor
Sang-Yup Lee
Kyung-Hee Chang
Ki-Chang Keum
Original Assignee
Medigenes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medigenes filed Critical Medigenes
Publication of BR0309890A publication Critical patent/BR0309890A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA PARA O TRATAMENTO DE LESõES". Contendo plasma sanguíneo ou soro e um método para tratamento de lesões eficientemente pela aplicação de tal composição no local da lesão para normalizar o tecido periférico próximo ao local.
BR0309890-7A 2002-05-09 2003-05-09 Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação BR0309890A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20020025669 2002-05-09
PCT/KR2003/000922 WO2003094937A1 (en) 2002-05-09 2003-05-09 A pharmaceutical composition for treatment of wounds containing blood plasma or serum

Publications (1)

Publication Number Publication Date
BR0309890A true BR0309890A (pt) 2005-05-10

Family

ID=29417347

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309890-7A BR0309890A (pt) 2002-05-09 2003-05-09 Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação

Country Status (9)

Country Link
US (2) US20050142208A1 (pt)
EP (1) EP1507543A4 (pt)
JP (1) JP2005530768A (pt)
KR (1) KR100518152B1 (pt)
CN (1) CN1668317B (pt)
AU (1) AU2003230321B8 (pt)
BR (1) BR0309890A (pt)
RU (1) RU2308954C2 (pt)
WO (1) WO2003094937A1 (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002030432A1 (en) 2000-06-23 2002-04-18 Cambridgemed, Inc Agent for reduction of scar formation by using wound alkalinization
US8293530B2 (en) * 2006-10-17 2012-10-23 Carnegie Mellon University Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
WO2003079985A2 (en) * 2002-03-18 2003-10-02 Carnegie Mellon University Method and apparatus for preparing biomimetic scaffold
US8529956B2 (en) * 2002-03-18 2013-09-10 Carnell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
US20100254900A1 (en) * 2002-03-18 2010-10-07 Campbell Phil G Biocompatible polymers and Methods of use
WO2003094937A1 (en) 2002-05-09 2003-11-20 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
US20070003552A1 (en) * 2002-07-09 2007-01-04 Gebbink Martijn F B Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation
EP1380290A1 (en) 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-beta structure pathway and its therapeutic relevance
US20050136126A1 (en) * 2003-03-17 2005-06-23 Cambridgemed, Inc. Agent for reduction of scar formation by using wound alkalinization
US20060142198A1 (en) * 2004-07-02 2006-06-29 Wound Care Partners Llc Compositions for treating wounds and processes for their preparation
JP2008531553A (ja) * 2005-02-25 2008-08-14 メディジーンズ カンパニー リミテッド 血漿または血清を含むアベリノ角膜ジストロフィー治療用の医薬組成物
US20090202980A1 (en) * 2005-03-21 2009-08-13 Crossbeta Biosciences B.V. Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With Blood Coagulation
US8114832B2 (en) * 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
WO2007008072A2 (en) * 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. CROSS-ß STRUCTURE BINDING COMPOUNDS
JP2009501215A (ja) * 2005-07-13 2009-01-15 クロスベータ、バイオサイエンセス、ベスローテン、フェンノートシャップ クロスβ構造によるアジュバンド形成法
US20090136587A1 (en) * 2005-08-11 2009-05-28 Medigenes Co., Ltd Pharmaceutical composition for the treatment of nerve damage comprising blood plasma or serum
KR100782333B1 (ko) * 2005-08-11 2007-12-06 메디제네스(주) 혈장 또는 혈청을 포함하는 신경손상 치료용 약학 조성물
US20070048391A1 (en) * 2005-08-23 2007-03-01 Cambridgemed, Inc. Composition for reduction of scar formation on wound scar
US7323184B2 (en) 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
CA2634045C (en) * 2005-12-20 2019-05-07 Swiss-American Products, Inc. Protease compositions for the treatment of damaged tissue
CA2645930A1 (en) * 2006-03-17 2007-09-27 Crossbeta Biosciences B.V. Methods of binding of cross-beta structures by chaperones
KR20070113876A (ko) * 2006-05-26 2007-11-29 메디제네스(주) 혈장성분을 함유하는 창상 치료용 약학 조성물
US8529959B2 (en) 2006-10-17 2013-09-10 Carmell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
EP2058000A1 (en) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Immunogenic compositions capable of activating T cells
EP2058001A1 (en) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Enhancement of immunogenicity of antigens
WO2009136747A2 (ko) * 2008-05-07 2009-11-12 한 쎌 주식회사 줄기세포 배양액을 포함하는 화장료 조성물 및 이의 제조방법
EP2198873A1 (en) * 2008-12-18 2010-06-23 Aposcience AG Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
EP2201954A1 (en) * 2008-12-18 2010-06-30 Aposcience AG Pharmaceutical preparation
US9867782B2 (en) 2009-04-09 2018-01-16 Entegrion, Inc. Spray-dried blood products and methods of making same
US20110142885A1 (en) * 2009-09-16 2011-06-16 Velico Medical, Inc. Spray-dried human plasma
US20160058718A1 (en) * 2014-09-02 2016-03-03 Michael Basara Formulation and method of treating chronic wounds and preventing bacterial infections
EP3092987A1 (de) * 2015-05-11 2016-11-16 3M Innovative Properties Company System zur wundbehandlung mit serum
CN108291202A (zh) 2015-11-16 2018-07-17 山原研 牛血清组合物和使用所述牛血清组合物作为添加剂培养细胞的方法
CA3027969A1 (en) * 2016-06-16 2017-12-21 Eye Care International, Llc Compositions and methods of treating dry eye syndrome and other traumatized non-keratinized epithelial surfaces
CN108586584A (zh) * 2018-05-03 2018-09-28 杭州史迪姆生物科技有限公司 功能多肽及其用途
CN119345230A (zh) * 2018-10-26 2025-01-24 万能溶剂有限公司 血浆和血浆组分用于改善疼痛的用途
KR102668789B1 (ko) * 2018-11-23 2024-05-24 (주)메디코스바이오텍 창상치료용 약학조성물
LT3923923T (lt) 2019-02-13 2024-09-25 DEBx Medical Holding B.V. Kompozicijos, skirtos nekrotinių arba infekuotų audinių pašalinimui nuo kūno paviršinių pažeidimų ir iš burnos ertmės
CN116135212A (zh) * 2021-11-18 2023-05-19 上海无名医药有限公司 胎牛血清在促进皮肤创伤修复中的应用
US11841189B1 (en) 2022-09-15 2023-12-12 Velico Medical, Inc. Disposable for a spray drying system
WO2024059770A1 (en) 2022-09-15 2024-03-21 Velico Medical, Inc. Rapid spray drying system
US12246266B2 (en) 2022-09-15 2025-03-11 Velico Medical, Inc. Disposable for a spray drying system
US12246093B2 (en) 2022-09-15 2025-03-11 Velico Medical, Inc. Methods for making spray dried plasma
US12539355B2 (en) 2022-09-15 2026-02-03 Velico Medical, Inc. Dryer for a spray drying system
US11975274B2 (en) 2022-09-15 2024-05-07 Velico Medical, Inc. Blood plasma product
US11998861B2 (en) 2022-09-15 2024-06-04 Velico Medical, Inc. Usability of a disposable for a spray drying plasma system
JP2025534394A (ja) 2022-09-29 2025-10-15 アドラ アニマル ヘルス コーポレーション 疼痛及び他の医学的状態の治療のための硫酸化グリコサミノグリカン及びそれに由来する断片の保存安定性製剤

Family Cites Families (160)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU589983A1 (ru) * 1974-07-16 1978-01-30 Харьковский Научно-Исследовательский Институт Протезирования,Ортопедии И Травмотологии Им.Проф.М.И. Ситенко Способ лечени трофических зв и длительно не заживающих ран
US4006220A (en) 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
ATE20824T1 (de) 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
EP0068047B1 (de) 1981-06-25 1986-07-23 Serapharm GmbH & Co. KG Angereichertes Plasmaderivat zur Unterstützung von Wundverschluss und Wundheilung
US5166331A (en) 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
HU190723B (en) 1983-06-03 1986-10-28 Caola Kozmetikai Cosmetical composition containing protein-trace element adducts and process for producing them
EP0171450A1 (de) 1984-08-14 1986-02-19 Österreichische Salen-Kunststoffwerk Gesellschaft m.b.H. Rohrverbindung für Kunststoffrohre und Verfahren zur Herstellung
US5409904A (en) 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US5165938A (en) 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
NL8520384A (nl) * 1984-11-29 1986-10-01 Curatech Inc Wondhelende middelen.
US4659572A (en) 1985-04-15 1987-04-21 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Burn wound dressing material
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IN166447B (pt) 1985-11-27 1990-05-12 Ethicon Inc
US4808576A (en) 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
DK475386D0 (da) 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
US5080893A (en) 1988-05-31 1992-01-14 University Of Florida Method for preventing surgical adhesions using a dilute solution of polymer
US5017229A (en) 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US4937270A (en) 1987-09-18 1990-06-26 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US4769234A (en) * 1987-10-06 1988-09-06 Peter M. Stephan Center Ltd. Skin care compositions containing polyvalent equine immune serum
US5209724A (en) 1988-04-11 1993-05-11 Dhaliwal Avtar S Composite anesthetic article and method of use
US4920104A (en) 1988-05-16 1990-04-24 Medchem Products, Inc. Sodium hyaluronate composition
US6010692A (en) 1988-05-31 2000-01-04 University Of Florida Research Foundation, Inc. Method and composition for preventing surgical adhesions and tissue damage
US5510418A (en) 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5017900A (en) 1989-02-10 1991-05-21 Hitachi Mizusawa Electronics Co., Ltd. Deflection yoke
SE8900586L (sv) 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
US6271216B1 (en) 1989-07-24 2001-08-07 Allergan Stable solution of hyaluronate in a balanced salt medium
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
US5196185A (en) 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
JP2945993B2 (ja) 1989-12-05 1999-09-06 武田薬品工業株式会社 外用剤
US5095037B1 (en) 1989-12-21 1995-12-19 Nissho Kk Combined anti-inflammatory agent
JPH03240738A (ja) * 1990-02-20 1991-10-28 Hoechst Japan Ltd 糖尿病性壊疽治療剤
US5183805A (en) * 1990-08-13 1993-02-02 Board Of Regents, The University Of Texas System Bioactive egf peptides for promotion of tissue regeneration and cancer therapy
US5824658A (en) 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (en) 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5639738A (en) 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5910489A (en) 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
SE501217C2 (sv) 1990-12-06 1994-12-12 Skandigen Ab Cellproliferationsmatris och användning därav
GR1002610B (el) 1991-01-02 1997-02-20 Johnson & Johnson Consumer Products Inc. Θεραπευτικες συνθεσεις πληγων που περιεχουν παραγοντα αναπτυξης ινοβλαστων και ασκορβικον οξυ.
DK0497724T3 (da) 1991-01-26 1996-04-29 Senju Pharma Co Middel til desintegration af galdesten
US5981606A (en) * 1991-03-01 1999-11-09 Warner-Lambert Company Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
US5149691A (en) * 1991-03-12 1992-09-22 Creative Biomolecules, Inc. Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
GR920100122A (el) 1991-04-05 1993-03-16 Ethicon Inc Πολυσακχαρίτες οι οποίοι περιέχουν καρβοξύλιο με σταυροειδείς δεσμούς δια την πρόληψιν της προσφύσεως.
US5234914A (en) 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
SE9101853D0 (sv) 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive
US6022866A (en) 1991-07-03 2000-02-08 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5834444A (en) 1991-07-03 1998-11-10 Hyal Pharmaceutical Corporation Hyaluronic acid and salts thereof inhibit arterial restenosis
US6103704A (en) 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5972906A (en) 1991-07-03 1999-10-26 Hyal Pharmaceutical Corporation Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
US6087344A (en) 1991-07-03 2000-07-11 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5990095A (en) 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5817642A (en) 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Clearing of atherosclerosis
US5977088A (en) 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
WO1994007505A1 (en) 1991-07-03 1994-04-14 Norpharmco Inc. Use of hyaluronic acid and forms to prevent arterial restenosis
US5792753A (en) 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
CA2071137A1 (en) 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
DE4200080A1 (de) * 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
US7060287B1 (en) 1992-02-11 2006-06-13 Bioform Inc. Tissue augmentation material and method
US6136793A (en) 1992-02-20 2000-10-24 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6114314A (en) 1992-02-21 2000-09-05 Hyal Pharmaceutical Corp. Formulations containing hyaluronic acid
IL101056A (en) 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
GB9205800D0 (en) 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
FR2695561B1 (fr) 1992-09-17 1994-12-02 Lvmh Rech Gie Composition cosmétique ou dermatologique contenant au moins une saponine de type ginsenoside, et ses applications, notamment pour le soin des cheveux.
US5550112A (en) 1992-12-30 1996-08-27 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US5681825A (en) 1993-03-15 1997-10-28 Lindqvist; Bengt Surgical method
KR100302935B1 (ko) 1993-03-30 2001-11-30 바트 루디거 사람혈액응고인자xiii과아프로티닌을포함하는약제학적조성물
US5744449A (en) 1993-05-10 1998-04-28 Lipps; Binie V. Lethal toxin neutralizing factors
IT1263394B (it) 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
US5529987A (en) 1993-08-04 1996-06-25 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
RU2082415C1 (ru) 1993-08-16 1997-06-27 Виктор Алексеевич Кольцов Способ заживления ткани
US5356683A (en) 1993-10-28 1994-10-18 Rohm And Haas Company Expandable coating composition
IL107578A (en) * 1993-11-11 1998-07-15 Yissum Res Dev Co Topical antibacterial preparation comprising silver sulfadiazine and collagen
US5962427A (en) * 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
JPH07267992A (ja) * 1994-03-31 1995-10-17 Hoechst Japan Ltd 新規なタンパク質ｐｈｂｐ−７０
US5604200A (en) 1994-05-02 1997-02-18 Taylor-Mccord; Darlene Wound therapeutic mixture containing medical grade hyaluronic acid and tissue culture grade plasma-fibronectin in a delivery system that creates a moist environment which simulates in utero healing
US6294202B1 (en) 1994-10-06 2001-09-25 Genzyme Corporation Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers
JP4010574B2 (ja) 1994-12-05 2007-11-21 電気化学工業株式会社 皮膚外用剤
US5585007A (en) 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5733545A (en) 1995-03-03 1998-03-31 Quantic Biomedical Partners Platelet glue wound sealant
US5925656A (en) 1995-04-10 1999-07-20 Dr. Reddy's Research Foundation Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5641483A (en) 1995-06-07 1997-06-24 Beaulieu; Andre Wound healing formulations containing human plasma fibronectin
US5591444A (en) 1995-07-28 1997-01-07 Isolagen Technologies, Inc. Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects
IL123500A (en) 1995-08-29 2003-06-24 Fidia Advanced Biopolymers Srl Composite biomaterials for preventing post-surgical adhesions of tissues
US5897880A (en) 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6387407B1 (en) 1995-09-29 2002-05-14 L.A.M. Pharmaceutical Corporation Topical drug preparations
JPH09124453A (ja) * 1995-11-02 1997-05-13 Japan Happy:Kk 皮膚外用剤
IT1282219B1 (it) 1995-12-20 1998-03-16 Fidia Advanced Biopolymers Srl Processo chimico fisico combinato per la preparazione di frazioni di acido ialuronico a basso peso molecolare caratterizzate da bassa
IT1287227B1 (it) 1996-04-04 1998-08-04 Fidia Spa In Amministrazione S Acido ialuronico quale componente del liquido di conservazione della cornea
IT1288290B1 (it) 1996-06-21 1998-09-11 Fidia Spa In Amministrazione S Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
US5866554A (en) 1996-07-19 1999-02-02 Shalaby; Shalaby W. Compositions for prevention of inflammation and adhesion formation and uses thereof
US6037331A (en) 1996-07-19 2000-03-14 Poly-Med, Inc. Compositions for prevention of inflammation and adhesion formation uses thereof
US6541460B2 (en) 1996-08-07 2003-04-01 George D. Petito Method for use of hyaluronic acid in wound management
US5863551A (en) * 1996-10-16 1999-01-26 Organogel Canada Ltee Implantable polymer hydrogel for therapeutic uses
DE69735604T2 (de) 1996-11-21 2006-11-16 Cedars-Sinai Medical Center, Los Angeles Hypophysentumor verursachende gene und verwandte produkte
US6063406A (en) 1997-04-18 2000-05-16 Chemcraft, Inc. Skin care compositions
US6596703B1 (en) 1997-07-11 2003-07-22 Jagotec Ag Promotion of wound healing utilizing steroids having reduced deteriorous systemic side effects typical of glucocorticoids, mineralocorticoids and sex steroids
WO1999010385A1 (en) 1997-08-22 1999-03-04 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, process for producing the same and medical material containing the same
FR2770779B1 (fr) 1997-11-10 2000-07-21 Bernstein Veronique Solute hypotonique ou hypoosmolaire au plasma utilise dans le traitement de la cellulite, les fibroses, et de l'hirsutisme
US6171611B1 (en) 1997-11-12 2001-01-09 Dante J. Picciano Iodine-containing nasal moisturizing saline and mouthwash solutions
WO1999031125A1 (en) * 1997-12-12 1999-06-24 University Of Southern California Wound healing compositions
US7691829B2 (en) 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US20020025921A1 (en) 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
IT1301994B1 (it) 1998-08-05 2000-07-20 Jasper Ltd Liability Co Derivati dell'acido ialuronico.
EP1129683A4 (en) 1998-11-10 2002-06-19 Denki Kagaku Kogyo Kk HYALURONIC ACID, METHOD FOR THE PRODUCTION THEREOF AND MEDICAL MATERIALS CONTAINING THIS
DK172900B1 (da) 1998-12-18 1999-09-27 Per Julius Nielsen Præparat samt kit til brug ved intraoculære operationer
IT1302534B1 (it) 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per
JP2002537324A (ja) 1999-02-23 2002-11-05 アンジオテック ファーマシューティカルズ，インコーポレイテッド 易感染性の体通路および体腔の完全性を改良するための組成物および方法
US7015198B1 (en) 1999-05-11 2006-03-21 Orentreich Foundation For The Advancement Of Science, Inc. Materials for soft tissue augmentation and methods of making and using same
US20030211166A1 (en) 2001-07-31 2003-11-13 Yamamoto Ronald K Microparticulate biomaterial composition for medical use
US6521223B1 (en) 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
US6262020B1 (en) 2000-02-15 2001-07-17 Alphamed Pharmaceuticals Corp. Topical wound therapeutic compositions
US6573249B2 (en) 2000-02-15 2003-06-03 Alphamed Pharmaceutical Corp. Topical wound therapeutic compositions
WO2002030432A1 (en) 2000-06-23 2002-04-18 Cambridgemed, Inc Agent for reduction of scar formation by using wound alkalinization
US6828308B2 (en) 2000-07-28 2004-12-07 Sinclair Pharmaceuticals, Ltd. Compositions and methods for the treatment or prevention of inflammation
IT1318649B1 (it) 2000-07-28 2003-08-27 Propharma S R L Ora Sinclair P Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
US7144729B2 (en) 2000-09-01 2006-12-05 Dfb Pharmaceuticals, Inc. Methods and compositions for tissue regeneration
US6924273B2 (en) 2000-10-03 2005-08-02 Scott W. Pierce Chondroprotective/restorative compositions and methods of use thereof
CN1156042C (zh) 2001-03-20 2004-06-30 北京科海迈迪生物技术有限责任公司 纳米α相氢氧化镍电极材料制造方法
US20030007957A1 (en) 2001-07-03 2003-01-09 Calvin Britton Novel wound healing composition not containing bovine-derived activating reagents
US20030152639A1 (en) 2001-07-03 2003-08-14 Calvin Britton Novel wound healing composition not containing bovine-derived activating reagents
US7008626B2 (en) 2001-11-05 2006-03-07 Seikagaku Corporation Medical composition for protuberance of epithelium
EP1465547A4 (en) 2001-12-28 2008-04-30 Genzyme Corp BIODEGRADABLE FOAM PACKAGING DEVICE AND ITS USE
CZ12015U1 (cs) 2002-01-18 2002-02-25 Cpn Spol. S R.O. Přípravek pro prevenci adheze bandáľe na ránu
US20030147830A1 (en) 2002-01-30 2003-08-07 The Procter & Gamble Company Topical skin and/or hair compositions containing protein
JPWO2003084571A1 (ja) 2002-04-08 2005-08-11 電気化学工業株式会社 骨感染症治療用組成物
ATE528009T1 (de) 2002-04-30 2011-10-15 Sifi Spa Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthalten
WO2003094937A1 (en) 2002-05-09 2003-11-20 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
AU2003278962B2 (en) 2002-06-20 2006-11-23 Novartis Consumer Health S.A. Nasal compositions comprising a mucopolysaccharide and propylene glycol
ITMI20021866A1 (it) 2002-08-30 2004-02-29 Luigi Allegra Preparazione farmaceutica in forma colloidale utile nella cura delle affezioni cutanee.
US20060258560A1 (en) 2002-09-30 2006-11-16 Chunlin Yang Dry tissue sealant compositions
DE10246340A1 (de) 2002-10-04 2004-04-29 Wohlrab, David, Dr. Kombinationspräparat aus Hyaluronsäure und mindestens einem Lokalanästhetikum und dessen Verwendung
US20040092482A1 (en) 2002-11-07 2004-05-13 Gupta Shyam K. Hydroxy acids based delivery systems for skin resurfacing and anti-aging compositions
US20040180622A1 (en) 2003-03-11 2004-09-16 Godfrey Timothy Gordon Coordinating multiple air-interface subsystems that serve a common host
US20050136126A1 (en) * 2003-03-17 2005-06-23 Cambridgemed, Inc. Agent for reduction of scar formation by using wound alkalinization
US20040197319A1 (en) 2003-03-24 2004-10-07 Paul Harch Wound healing composition derived from low platelet concentration plasma
EP1627047A4 (en) 2003-05-07 2008-07-16 Jolla Inst For Molecular Medic METHODS FOR FACILITATING RECOVERY OF FUNCTIONS OF ENDOGENOUS, IMPLANTED OR TRANSPLANTED STEM CELLS BY MEANS OF HYALURONIC ACID OF HIGH MOLECULAR WEIGHT
US7262179B2 (en) 2003-05-28 2007-08-28 Bristol-Myers Squibb Company Wound care compositions
ES2226567B1 (es) 2003-06-20 2006-07-01 Universidad De Santiago De Compostela Nanoparticulas de acido hialuronico.
ITMI20031291A1 (it) 2003-06-25 2004-12-26 Ricerfarma Srl Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
DE10356248A1 (de) 2003-11-13 2005-06-23 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
US8124120B2 (en) 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
US20050142161A1 (en) 2003-12-30 2005-06-30 Freeman Lynetta J. Collagen matrix for soft tissue augmentation
AU2005209322B2 (en) 2004-01-28 2011-05-19 The Regents Of The University Of California Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
CN1270812C (zh) 2004-02-04 2006-08-23 刘寿山 一种超滤装置及其应用方法
US20050191286A1 (en) 2004-02-09 2005-09-01 Gandy James B. Lyophilized platelet rich plasma for the use in wound healing (chronic or acute) and bone or tissue grafts or repair
US20050180938A1 (en) 2004-02-17 2005-08-18 Beatrice Novelli Skin care cosmetic regime and kit
US20050220882A1 (en) 2004-03-04 2005-10-06 Wilson Pritchard Materials for medical implants and occlusive devices
US7956180B2 (en) 2004-05-27 2011-06-07 Novozymes A/S Dried and agglomerated hyaluronic acid product
US20050272695A1 (en) 2004-05-27 2005-12-08 Novozymes Biopolymer A/S Fast dissolving dried hyaluronic acid product
US20060040895A1 (en) 2004-08-19 2006-02-23 Kipling Thacker Aesthetic use of hyaluronan
JP2008515909A (ja) * 2004-10-07 2008-05-15 デュラメド ファーマシューティカルズ インコーポレーティッド 上昇用量延長サイクル療法を利用するホルモン処置の方法
US20060194759A1 (en) 2005-02-25 2006-08-31 Eidelson Stewart G Topical compositions and methods for treating pain and inflammation
US7399783B2 (en) 2005-06-22 2008-07-15 The Quigley Corporation Methods for the treatment of scar tissue
US7491709B2 (en) 2005-07-01 2009-02-17 Wayne Carey Treatment with hyaluronic acid
US20070048391A1 (en) 2005-08-23 2007-03-01 Cambridgemed, Inc. Composition for reduction of scar formation on wound scar
US7323184B2 (en) 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
US20070048387A1 (en) 2005-09-01 2007-03-01 Edwards Jeffrey D Tissue disruption treatment and composition for use thereof
US20070087061A1 (en) 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components

Also Published As

Publication number Publication date
US8017157B2 (en) 2011-09-13
WO2003094937A1 (en) 2003-11-20
CN1668317B (zh) 2010-04-28
CN1668317A (zh) 2005-09-14
AU2003230321B8 (en) 2009-07-30
AU2003230321B2 (en) 2007-03-08
EP1507543A1 (en) 2005-02-23
JP2005530768A (ja) 2005-10-13
US20070148142A1 (en) 2007-06-28
EP1507543A4 (en) 2006-07-26
KR100518152B1 (ko) 2005-09-29
RU2004135913A (ru) 2005-07-10
AU2003230321A1 (en) 2003-11-11
US20050142208A1 (en) 2005-06-30
RU2308954C2 (ru) 2007-10-27
KR20040068172A (ko) 2004-07-30

Similar Documents

Publication Publication Date Title
BR0309890A (pt) Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
TW200509956A (en) Compositions and methods for treatment of rosacea
BRPI0414455A (pt) métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
BR0015604A (pt) Método para o tratamento de cicatrizes hipertróficas de modo a reduzir o tamanho e/ou melhorar a aparência das mesmas, composições para tratar condições adversas da pele, e, para reduzir o tamanho e melhorar a aparência de cicatrizes hipertróficas
BR0114576A (pt) Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto
NO20061325L (no) Kombinasjon av legemidler for behandling av neoplasmer
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
CY1107484T1 (el) Παραγωγα γκελνταναμυκινης χρησιμοποιουμενα για τη θεραπεια καρκινου
BRPI0013010B8 (pt) formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
ATE355058T1 (de) Verfahren zur behandlung von akne vulgaris mit einer avermectin-verbindung
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
BR0312597A (pt) Combinações de drogas para o tratamento de neoplasmas
ATE407685T1 (de) Verbindungen und methoden zur behandlung von hautverletzungen
PT1299130E (pt) Processo papa o tratamento e prevencao de doencas infecciosas
WO2004091540A3 (en) Methods of treating pain and compositions for use therefor
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
BR0214481A (pt) Método e composição para potenciação de um analgésico opiáceo
BR0313117A (pt) Método para a produção de um efeito redutor de permeabilidade vascular e/ou antiangiogênico em um animal de sangue quente tal como um humano, método para o tratamento de um câncer em um animal de sangue quente tal como um humano, composição farmacêutica, kit, e, uso de zd6474 ou de um seu sal farmaceuticamente aceitável e de zd1839 ou de um seu sal farmaceuticamente aceitável
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
TW200505473A (en) Compositions and methods for treatment of psoriasis
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
BR0313116A (pt) Método para a produção de um efeito redutor de permeabilidade vascular e/ou antiangiogênico em um animal de sangue quente tal como um humano, método para o tratamento de um câncer em um animal de sangue quente tal como humano, e, uso de zd6474 ou de um seu sal farmaceuticamente aceitável.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 8A E 9A ANUIDADES.